What did CDH Investments Consortium pay for Sirtex Medical?

CDH Investments Consortium acquired Sirtex Medical for $1.40B in 2018 (24.7x EBITDA), equivalent to 8.60x revenue. Target revenue was approximately $163.5M. Target EBITDA was approximately $56.7M.

What does Sirtex Medical do?

Sirtex Medical is a medical devices business.

What multiple did CDH Investments Consortium pay for Sirtex Medical?

24.7x EBITDA and 8.60x revenue, based on disclosed deal value of $1.40B and disclosed financials.

M&A TRANSACTION · 2018

Sirtex Medical acquired by CDH Investments Consortium

$1.40B· 24.7x EBITDA· 8.60x revenue

Target

Sirtex Medical

Acquirer

CDH Investments Consortium

Disclosed financials at time of acquisition

Revenue

$163.5M

EBITDA

$56.7M

Deal Value

$1.40B

EV/EBITDA

24.7x

Context

This $1.40B acquisition of Sirtex Medical by CDH Investments Consortium sits in the medical devices sub-vertical. The 24.7x EBITDA multiple paid in 2018 can be compared against the population median for medical devices transactions of similar size on our Medical Devices valuation hub.

Source

Data sourced from Press releases and earnings releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own medical devices

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the Sirtex Medical acquisition.

Citation: ExitValue.ai. (2018). Sirtex Medical acquired by CDH Investments Consortium. https://exitvalue.ai/deals/sirtex-medical-acquired-by-cdh-investments-consortium-hc-2018-0169